Devicor Medical Products has announced it has received FDA approval for a biopsy system, according to a news release.
The Mammotome revolve is a dual vacuum-assisted biopsy system which features an advanced specimen management system and the DualVac vacuum technology that gives clinicians the ability to secure larger contiguous tissue samples, according to the company.
"Mammotome revolve uses breakthrough technology that offers peace of mind for clinicians and the patients they treat," says Devicor President and CEO Tom Daulton, in the release. "With this new product, clinicians can be confident that patients are more likely to have a less painful and traumatic experience."
Mammotome revolve is currently available in limited market release in the United States, Canada and Europe. It is expected to be available in full market release by spring of 2013.
Devicor Medical Products is headquartered in Cincinnati.
Related Articles on FDA Clearances:
IRIDEX Receives FDA Clearance for New Laser Delivery System
Ivera Medical Receives FDA Clearance for Disinfection Device
AtCor Medical Receives FDA Clearance for Blood Pressure Cuff-Based System